Boardroom Alpha
Boardroom Alpha
CFBK · Current Report (Form 8-K) · Filed March 26, 2026

Cf Bankshares Inc — Current Report (Form 8-K)

Form
8-K
Filed
March 26, 2026
Period
Mar 25, 2026
Ticker
CFBK
Accession
0001193125-26-125864
Boardroom Alpha · Filing insights

Brad Ringwald appointed to CF Bankshares Inc. and CFBank boards to fill Rana vacancy; term through the 2026 annual meeting.

About Cf Bankshares Inc
Market cap
$225M
1Y TSR
+47.6%
3Y TSR
+26.5%
Board grade
A-
Sector
Financial Services
CEO
Timothy T O'Dell
Last annual meeting: May 27, 2026 · View full Cf Bankshares Inc profile →
8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 25, 2026

 

 

CF BANKSHARES INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

0-25045

34-1877137

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

C/O CFBANK

4960 EAST DUBLIN GRANVILLE RD

SUITE 400

 

COLUMBUS, Ohio

 

43081

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (614) 334-7979

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

(Voting) Common Stock, $.01 par value

 

CFBK

 

The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 25, 2026, the Boards of Directors of CF Bankshares Inc. (the “Company”) and CFBank, National Association, the Company’s wholly owned subsidiary bank (“CFBank”), appointed Bradley Ringwald as a director to fill the vacancies created on the Boards of Directors of the Company and CFBank resulting from the previously reported resignation of Sundeep Rana. Mr. Ringwald was appointed to the same class of directors in which Mr. Rana previously served with a term expiring at the Company’s 2026 Annual Meeting of Stockholders.

Mr. Ringwald has served as President of CFBank since October 2022, and he previously served as Executive Vice President and Chief Commercial Banking Officer of CFBank from November 2020 to October 2022.

Mr. Ringwald was appointed by the Board of Directors of the Company upon the recommendation of the Corporate Governance and Nominating Committee. There was no arrangement or understanding between Mr. Ringwald and any other persons pursuant to which Mr. Ringwald was selected as a director. Neither Mr. Ringwald nor any member of his immediate family has had any business transactions or relationships with the Company or CFBank that would require disclosure under Item 404(a) of SEC Regulation S-K, except for Mr. Ringwald’s employment as an executive officer of CFBank, and compensation paid to Mr. Ringwald in such capacity, which is disclosed in the Company’s definitive proxy statements filed with the Securities and Exchange Commission. However, Mr. Ringwald and members of his immediate family have had, and/or may in the future enter into, banking transactions with CFBank in the ordinary course of business and in compliance with applicable laws and regulations.

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

CF Bankshares Inc.

 

 

 

 

Date:

March 26, 2026

By:

/s/ Kevin J. Beerman

 

 

 

Kevin J. Beerman
Executive Vice President and Chief Financial Officer

 


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Cf Bankshares Inc (CFBK)

Reference

Frequently asked questions

When did Cf Bankshares Inc file this 8-K?
Cf Bankshares Inc (CFBK) filed this Current Report (Form 8-K) with the SEC on March 26, 2026. The accession number assigned by EDGAR is 0001193125-26-125864.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Brad Ringwald appointed to CF Bankshares Inc. and CFBank boards to fill Rana vacancy; term through the 2026 annual meeting. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Cf Bankshares Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Cf Bankshares Inc has filed under CIK 1070680, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer